Researchers use blood serum markers to develop lupus risk index
Researchers have developed an index that identifies the risk for lupus based on the presence and amount of IgG and IgM antibodies and levels of C1q...
List view / Grid view
News
RNA-modifying tool corrects genetic diseases
Researchers have developed a small-molecule-based tool that acts on RNA to selectively delete certain gene products...
Changes to specific MicroRNA involved in development of Lou Gehrig’s disease
A new Tel Aviv University study identifies a previously unknown mechanism involved in the development of Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS).
Genomic medicine may one day revolutionise cardiovascular care
A new scientific statement summarises the state-of-the-science of genomic medicine...
IL-25 molecule linked to nasal polyps
Study could lead to the development of new treatments for common sinus conditions...
AIBP injection alleviates chemotherapy pain for months in mice
Protein inhibits inflammatory response underlying chronic pain processing; may provide an alternative to opioids for severe, persistent pain...
Gut microbiome can control anti-tumour immune function in liver
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver...
Researchers in Spain elucidate complete epigenome for leukaemia
A team of researchers in Spain show for the first time the complete epigenome of chronic lymphocytic leukaemia, the most common type of leukaemia.
Immune processes offer insights into triple-negative breast cancer
Researchers have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment...
Tau mutations may increase cancer risk
Mutations in the protein tau, commonly associated with neurodegenerative disorders, may serve as a novel risk factor for cancer...
Three new genes linked to Alzheimer’s identified
An international research team has identified three new genes linked to the risk of Alzheimer’s disease...
Artificial enzyme – metalloenzyme – activates complex reaction cascade in mammalian cells
24 May 2018 | By
Scientists in Switzerland have constructed an enzyme than can penetrate a mammalian cell and accelerate the release of a hormone. This then activates a gene switch that triggers the creation of a fluorescent protein.
Profiling the genome hundreds of variations at a time
A CRISPR-Cas9 high-throughput strategy creates the possibility to rapidly profile and identify genes and DNA sequence variations key to different traits and diseases.
Scientists reveal model that estimates lifetime risk of developing Alzheimer’s dementia
The Alzheimer’s Association have published a study wherein a model estimates the lifetime risk of an individual developing Alzheimer’s disease dementia. The risk varies with such factors as age and gender, and crucially takes account of preclinical biological changes.
Link between TB and Parkinson’s disease identified
The mechanism our immune cells use to clear bacterial infections like tuberculosis might also be implicated in Parkinson's disease...